IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 321 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,159,000 | -64.0% | 23,050 | -63.7% | 0.49% | -35.3% |
| Q3 2017 | $3,216,000 | -17.8% | 63,440 | -17.5% | 0.76% | -2.7% |
| Q2 2017 | $3,913,000 | -9.9% | 76,930 | -28.8% | 0.78% | +65.5% |
| Q1 2017 | $4,343,000 | -9.4% | 108,040 | +7.8% | 0.47% | +0.6% |
| Q4 2016 | $4,791,000 | -2.7% | 100,190 | -25.5% | 0.47% | +46.4% |
| Q3 2016 | $4,926,000 | +36.9% | 134,450 | -13.0% | 0.32% | +83.3% |
| Q2 2016 | $3,598,000 | -44.8% | 154,490 | -4.0% | 0.17% | -40.2% |
| Q1 2016 | $6,516,000 | -17.2% | 160,910 | +26.7% | 0.29% | -5.2% |
| Q4 2015 | $7,866,000 | – | 127,030 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |